Figure 5.

Versican (VCAN) immunoreactivity in endometrial tissue from women without endometriosis (A-C), and women with mild (D-F), and severe (G-I) endometriosis in the proliferative ([PE] n = 4, n = 4, and n = 5, respectively; A, D, G), early secretory ([ESE]; n = 4, n = 3, and n = 7, respectively; B, E, H), and mid-secretory ([MSE]; n = 4, n = 3, and n = 5, respectively; C, F, I) phases of the menstrual cycle. Mouse lung tissue (J) and mouse ovary (K) were used as positive controls. L indicates negative control, nonimmune IgG-treated human endometrium; Le, luminal epithelium; ge, glandular epithelium; st, stroma; v, blood vessel. Magnification ×200.